Diabetes mellitus is a disease by which larger population of animals suffer. Diabetes early symptoms recognition can help to control it in animals. Generally in animals these symptoms include, weight loss, cloudy eyes, and recurring chronic infections. There are many recommended insulin therapy approved for cats and dogs for controlling the glycemic conditions such as porcine insulin zinc suspension and vetsulin. Manufacturers have designed various technological advanced insulin delivery devices like insulin pen.
MARKET SCOPE
The "Global Veterinary Insulin Drugs Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the veterinary insulin drugs market with detailed market segmentation by drug type, device type, end user, and geography. The report provides key statistics on the market status of the leading veterinary insulin drugs market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
-Based on drug type, the global veterinary insulin drugs market is segmented into rapid acting, intermediate acting, long acting.
-On the basis of device type, the market is bifurcated into insulin delivery pens, insulin syringes.
-On the basis of end-users, the market is bifurcated into veterinary clinics, home care settings, veterinary hospitals.
MARKET DYNAMICS
Drivers:
-Increasing prevalence of disease and growing awareness regarding animal health and hygiene drive the growth of veterinary insulin drugs market.
-Rising prevalence of obesity in pets and technological advancement in veterinary insulin devices boosts the market growth.
-Increasing government initiative towards animal health and funding for development of product fuel the market growth.
Restraints:
-Lack of healthcare infrastructure for pets.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The veterinary insulin drugs market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the veterinary insulin drugs market in these regions.
IMPACT OF COVID-19 ON VETERINARY INSULIN DRUGS MARKET
COVID-19 first began in Wuhan (China) during December 2019, and since then, it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, UK, Turkey, Italy, and Spain are some of the worst affected countries in terms of confirmed cases and reported deaths. The treatment of veterinary diabetes might be delayed due to the pandemic. As during the outbreak, mainly all appointments were postponed and cancelled. Currently, veterinary practices are facing various challenges such as unavailability of raw materials, and treatment priority setting. However, the demand for treatment of animals suffering from diabetes has not reduced but due to scarcity of personal protective equipment for veterinarians, and limited hospital capacity have negatively impacted the market. Overall, growth can be witnessed mainly due to the companies resuming their operations and adapting to the new normal.
MARKET PLAYERS
The report covers key developments in the veterinary insulin drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market players from veterinary insulin drugs market are anticipated to have lucrative growth opportunities in the future with the rising demand for veterinary insulin drugs in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the veterinary insulin drugs market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
-Allison Medical
-Boehringer Ingelheim Vetmedica Inc.
-Apotex Inc.
-Merck & Co.Inc,
-Becton, Dickinson and Company
-Henry Schein Animal Health
-MED TRUST
-UltiMed Inc.
-Zoetis Inc
-Akston Biosciences